<?xml version="1.0" encoding="iso-8859-1"?><CoCoMacExport xmlns="http://www.cocomac.org" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.cocomac.org http://www.cocomac.org/cocomac.xsd">
<Header>
<Creator>CoCoMac-Online</Creator>
<CoCoMacVersion>20</CoCoMacVersion>
<ExportDate>2013-10-30T15:25:15+01:00</ExportDate>
<DataType>BibliographicData</DataType>
<DataType>BrainMapData</DataType>
<Feedback>
<Query>
<HttpString>Search=LITERATURE&amp;OutputType=XML_BROWSER&amp;SearchString=('LCRM01') [LITID]&amp;Details=</HttpString>
<SearchString>('LCRM01') [LITID]</SearchString>
<SqlString>SELECT  Top 32767  ID,Literature FROM Literature WHERE  (Literature ='LCRM01') </SqlString>
</Query>
<Results>1</Results>
</Feedback>
<Comments>CocoMac XML Output</Comments>
</Header>
<BibliographicData>
<ID>LCRM01</ID>
<Authors>
<Author>
<Initials>G</Initials>
<LastName>Luppino</LastName>
</Author>
<Author>
<Initials>R</Initials>
<LastName>Calzavara</LastName>
</Author>
<Author>
<Initials>S</Initials>
<LastName>Rozzi</LastName>
</Author>
<Author>
<Initials>M</Initials>
<LastName>Matelli</LastName>
</Author>
</Authors>
<Title>Projections from the superior temporal sulcus to the agranular frontal cortex in the macaque.</Title>
<Year>2001</Year>
<Journal>
<JournalName>Eur. J. Neurosci.</JournalName>
<Volume>14</Volume>
<Pages>1035-1040</Pages>
<PubMedID>11595042</PubMedID>
</Journal>
</BibliographicData>
<MapData>
<BrainMap>
<IDBrainMap>LCRM01</IDBrainMap>
<BrainSiteList>
<BrainSite>
<ID_BrainSite>LCRM01-F2d</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>F2d</Acronym>
<FullName>F2 sector located around the superior precentral dimple</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>LCRM01-F2vr</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>F2vr</Acronym>
<FullName>ventrorostral part of Area F2</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>LCRM01-F7-nonSEF</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>F7-nonSEF</Acronym>
<FullName>remaining part of Area F7</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>LCRM01-F7-SEF</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>F7-SEF</Acronym>
<FullName>supplementary eye field part of Area F7 (dorsorostral)</FullName>
<DefType>A</DefType>
</BrainSite>
</BrainSiteList>
</BrainMap>
</MapData>
<ExperimentalData>
<ID_Literature>LCRM01</ID_Literature>
<Method>
<TracerSubstance>
<ID_Tracer>CTB-gold</ID_Tracer>
<FullName>Gold-conjugated cholera toxin B subunit</FullName>
<Anterograde>false</Anterograde>
<Retrograde>true</Retrograde>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>P</InjectionMethod>
<SurvivalTime>7d</SurvivalTime>
<Thickness_Sections>60</Thickness_Sections>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>LCRM01-F2vr</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>L</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>1,0</Volume>
<Concentration>0,5%</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>LCRM01</ID_Literature>
<TextPageNumber>p.1037</TextPageNumber>
<FigureNumber>Fig.1</FigureNumber>
<Quotation>&amp;quot;Area F2 was injected in four cases. Labelling within the uSTS was,however, observed only following injections in F2vr (Cases 18l and11r FB),..&amp;quot;</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>DU86-MST</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>L</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>3</Degree>
<PDC_Density>F</PDC_Density>
</Density>
<Reference>
<ID_Literature>DU86</ID_Literature>
<TextPageNumber>p.1037</TextPageNumber>
<FigureNumber>Fig.2</FigureNumber>
<Quotation>&amp;quot;Relatively dense labelling was concentrated in the caudal andventral part of the uSTS, at a level caudal to the end of the lateralfissure. This labelling extended, ventrally, up to the border with thefloor, slightly invading the dorsalmost part of the floor itself.&amp;quot;</Quotation>
</Reference>
</LabelledBrainSite>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>DU86-PP</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>L</Hemisphere>
<PDC_Site>P</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>1</Degree>
<PDC_Density>F</PDC_Density>
</Density>
<Reference>
<ID_Literature>DU86</ID_Literature>
<TextPageNumber>p.1037</TextPageNumber>
<FigureNumber>Fig.2</FigureNumber>
<Quotation>&amp;quot;Relatively dense labelling was concentrated in the caudal andventral part of the uSTS, at a level caudal to the end of the lateralfissure. This labelling extended, ventrally, up to the border with thefloor, slightly invading the dorsalmost part of the floor itself.&amp;quot;</Quotation>
</Reference>
</LabelledBrainSite>
</Injection>
</Method>
<Method>
<TracerSubstance>
<ID_Tracer>DY</ID_Tracer>
<FullName>Diamidino Yellow</FullName>
<Anterograde>false</Anterograde>
<Retrograde>true</Retrograde>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>P</InjectionMethod>
<SurvivalTime>12-14d</SurvivalTime>
<Thickness_Sections>60</Thickness_Sections>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>LCRM01-F7-nonSEF</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>R</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,4</Volume>
<Concentration>2%</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>DU86</ID_Literature>
<TextPageNumber>p.1036</TextPageNumber>
<FigureNumber>Fig.1</FigureNumber>
<Quotation>&amp;quot;In Cases 11r (injectionsite shown in Fig. 1, lower part) and 13l, tracers injections involvedthe ventral and caudal parts of F7 (F7±not SEF), respectively.&amp;quot;</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>AAES90-7a</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>R</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>s</Location>
<Density>
<Degree>X</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>AAES90</ID_Literature>
<TextPageNumber>p.1037</TextPageNumber>
<FigureNumber>Fig.2</FigureNumber>
<Quotation>&amp;quot; Whilst in Case 11r DY (Fig. 2C) the labelling was almost restricted to the caudalmost and dorsalmost part of the uSTS, ..&amp;quot;</Quotation>
</Reference>
</LabelledBrainSite>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>MLR91-F6</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>L</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,2</Volume>
<Concentration>2%</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>AAES90</ID_Literature>
<TextPageNumber>p.1036</TextPageNumber>
<FigureNumber>Fig.1</FigureNumber>
<Quotation>&amp;quot;Area F6 was injected in two cases. In case 4l (injection site shown in Fig.1, lower part), DY-labelled cells..&amp;quot;</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>BDG81-STP</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>L</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>s</Location>
<Density>
<Degree>1</Degree>
<PDC_Density>F</PDC_Density>
</Density>
<Reference>
<ID_Literature>BDG81</ID_Literature>
<TextPageNumber>p.1036</TextPageNumber>
<FigureNumber>Fig.2</FigureNumber>
<Quotation>&amp;quot; DY-labelled cells were located in the fundus of the sulcus, slightly extending also in the dorsal bank, in correspondence of the rostral end of the floor and therefore in area STP (Fig. 2A).&amp;quot;</Quotation>
</Reference>
</LabelledBrainSite>
</Injection>
</Method>
<Method>
<TracerSubstance>
<ID_Tracer>FB</ID_Tracer>
<FullName>Fast Blue</FullName>
<Anterograde>false</Anterograde>
<Retrograde>true</Retrograde>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>P</InjectionMethod>
<SurvivalTime>12-14d</SurvivalTime>
<Thickness_Sections>60</Thickness_Sections>
<Animals>
<Nbr_AllAnimals>1</Nbr_AllAnimals>
<Nbr_AllFemaleAnimals>?</Nbr_AllFemaleAnimals>
<AgeRange>?</AgeRange>
<WeightRange>?</WeightRange>
<Details>
<MacaqueSpecies>Macaca fascicularis</MacaqueSpecies>
<Sex>?</Sex>
<Number>1</Number>
</Details>
</Animals>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>LCRM01-F7-SEF</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>L</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0,2</Volume>
<Concentration>3%</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>BDG81</ID_Literature>
<TextPageNumber>p.1036</TextPageNumber>
<FigureNumber>Fig.1</FigureNumber>
<Quotation>&amp;quot;In Case 2l, FB was injected inthe dorsal part of F7 corresponding to the supplementary eye fieldF7-supplementary eye field (SEF), Fig. 1, lower part, as definedfollowing extensive physiological mapping.</Quotation>
</Reference>
<LabelledBrainSite>
<BrainSite>
<ID_BrainSite>BDG81-STP</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>L</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>P</EC>
<PDC_EC>F</PDC_EC>
</Extent>
</BrainSite>
<Course>I</Course>
<Location>S</Location>
<Density>
<Degree>X</Degree>
<PDC_Density>-</PDC_Density>
</Density>
<Reference>
<ID_Literature>BDG81</ID_Literature>
<TextPageNumber>p.1036</TextPageNumber>
<FigureNumber>Fig.2</FigureNumber>
<Quotation>&amp;quot; Almost all the labelling was located in the rostral two-thirds of the uSTS, in correspondencewith the fundus, but also extending in the whole extent of the dorsal bank and therefore occupying a large part of area STP (Fig. 2B).&amp;quot;</Quotation>
</Reference>
</LabelledBrainSite>
</Injection>
</Method>
</ExperimentalData>
</CoCoMacExport>
